Jones Trading initiates Buy on IN8bio shares with $5 price target by Investing.com
© Reuters. On Tuesday, Jones Trading initiated coverage on IN8bio Inc. (NASDAQ:INAB), a biotechnology company focused on developing cancer treatments, with a Buy rating and a stock price target of $5.00. The company highlighted IN8bio’s commitment to oncology and its unique approach in the γδ T-cell-based therapeutic landscape, particularly in the context of leukemia maintenance … Read more